Advanced search
Publication Cover
Leukemia & Lymphoma Volume 64, 2023 - Issue 11
Submit an article Journal homepage
130
Views
1
CrossRef citations to date
0
Altmetric
Letters to the Editor

Digital droplet PCR for T315I BCR::ABL1 KD mutation assessment in adult Ph-positive acute lymphoblastic leukemia with a minimal residual disease increase

Deborah Cardinalia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-3508-0293View further author information
ORCID Icon,
Marco Beldinanzia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyORCID Iconhttps://orcid.org/0000-0003-4895-3452View further author information
ORCID Icon,
Michela Ansuinellia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyORCID Iconhttps://orcid.org/0000-0002-3424-915XView further author information
ORCID Icon,
Loredana Eliaa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Irene Della Starzaa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, Italy;b Fondazione GIMEMA Onlus, Rome, ItalyORCID Iconhttps://orcid.org/0000-0001-7909-8642View further author information
ORCID Icon,
Vittorio Bellomarinoa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Mabel Matarazzoa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Mariangela Di Trania Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Mattia Colaa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Prassede Salutaric Department of Hematology Ospedale Civile, Pescara, ItalyView further author information
,
Michele Cedroned UOC Ematologia, Ospedale San Giovanni Addolorata, Rome, ItalyView further author information
,
Renato Bassane Hematology Unit, Ospedale dell’Angelo and Ospedale Ss Giovanni e Paolo, Mestre Venezia, ItalyORCID Iconhttps://orcid.org/0000-0001-8214-2894View further author information
ORCID Icon,
Marco De Gobbif Department of Clinical and Biological Sciences, Haematopoietic Stem Cell Transplant Unit, University of Turin, San Luigi Gonzaga Hospital, Orbassano, ItalyView further author information
,
Matteo Giovanni Della Portag IRCCS Humanitas Research Hospital, Rozzano, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-1984-1614View further author information
ORCID Icon,
Mariacarla De Simoneh Division of Hematology, Cardarelli Hospital, Napoli, ItalyView further author information
,
Caterina Alatii Division of Hematology, Azienda Ospedaliera ‘‘Bianchi Melacrino Morelli’, Reggio Calabria, ItalyView further author information
,
Nicola Stefano Fracchiollaj UOC Oncoematologia, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Università degli Studi di Milano, Milan, ItalyORCID Iconhttps://orcid.org/0000-0002-5356-8690View further author information
ORCID Icon,
Monia Lunghik Division of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, ItalyView further author information
,
Tamara Intermesolil Department of Oncology, Hematology University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, ItalyView further author information
,
Valeria Cardinalim Department of Medicine and Surgery, Institute of Hematology, Centro di Ricerca Emato-Oncologica (CREO), University of Perugia, Perugia, ItalyView further author information
,
Antonino Mulèn UOC, Ospedali Riuniti, Villa Sofia-Cervello, Palermo, ItalyView further author information
,
Anna Guarinia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
,
Robin Foàa Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyView further author information
&
Sabina Chiarettia Hematology, Department of Translational and Precision Medicine, “Sapienza” University of Rome, Rome, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-8499-4492View further author information
ORCID Icon show all
Pages 1884-1887 | Received 27 Apr 2023, Accepted 06 Jul 2023, Published online: 15 Jul 2023

References

  • Nowell PC, Hungerford DA. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst. 1960;25:85–109.
  • Burmeister T, Schwartz S, Bartram CR, et al. Patients’ age and BCR-ABL frequency in adult B-precursor ALL: a retrospective analysis from the GMALL study group. Blood. 2008;112(3):918–919. doi:10.1182/blood-2008-04-149286
  • Chiaretti S, Vitale A, Cazzaniga G, et al. Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica. 2013;98(11):1702–1710. doi:10.3324/haematol.2012.080432
  • Foà R, Chiaretti S. Philadelphia chromosome-positive acute lymphoblastic leukemia. N Engl J Med. 2022;386(25):2399–2411. doi:10.1056/NEJMra2113347
  • Foà R, Bassan R, Vitale A, GIMEMA Investigators., et al. Dasatinib-blinatumomab for Ph-positive acute lymphoblastic leukemia in adults. N Engl J Med. 2020;383(17):1613–1623. doi:10.1056/NEJMoa2016272
  • Jabbour E, Short NJ, Jain N, et al. Ponatinib and blinatumomab for Philadelphia chromosome-positive acute lymphoblastic leukaemia: a US, single-centre, single-arm, phase 2 trial. Lancet Haematol. 2023;10(1):e24–e34. doi:10.1016/S2352-3026(22)00319-2
  • Soverini S, De Benedittis C, Papayannidis C, et al. Clinical impact of low-burden BCR-ABL1 mutations detectable by amplicon deep sequencing in Philadelphia-positive acute lymphoblastic leukemia patients. Leukemia. 2016;30(7):1615–1619. doi:10.1038/leu.2016.17
  • Soverini S, Hochhaus A, Nicolini FE, et al. BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet. Blood. 2011;118(5):1208–1215. doi:10.1182/blood-2010-12-326405
  • Soverini S, De Santis S, Martelli M, et al. Droplet digital PCR for the detection of second-generation tyrosine kinase inhibitor-resistant BCR::ABL1 kinase domain mutations in chronic myeloid leukemia. Leukemia. 2022;36(9):2250–2260. doi:10.1038/s41375-022-01660-8
  • Della Starza I, De Novi LA, Santoro A, et al. Digital droplet PCR is a reliable tool to improve minimal residual disease stratification in adult Philadelphia-negative acute lymphoblastic leukemia. J Mol Diagn. 2022;24(8):893–900. doi:10.1016/j.jmoldx.2022.04.014
  • Ansuinelli M, Della Starza I, Lauretti A, et al. Applicability of droplet digital polymerase chain reaction for minimal residual disease monitoring in Philadelphia-positive acute lymphoblastic leukaemia. Hematol Oncol. 2021;39(5):680–686. doi:10.1002/hon.2913
  • Drandi D, Genuardi E, Dogliotti I, et al. Highly sensitive MYD88L265P mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia. Haematologica. 2018;103(6):1029–1037. doi:10.3324/haematol.2017.186528
  • Nystrand CF, Ghanima W, Waage A, et al. JAK2 V617F mutation can be reliably detected in serum using droplet digital PCR. Int J Lab Hematol. 2018;40(2):181–186. doi:10.1111/ijlh.12762
  • Skórka K, Chojnacki M, Masternak M, et al. The predominant prognostic significance of NOTCH1 mutation defined by emulsion PCR in chronic lymphocytic leukemia. Cancer Manag Res. 2021;13:3663–3674. doi:10.2147/CMAR.S302245

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.